Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ying Huang"'
Autor:
Limei Zhang, Chengcheng Guo, Suxia Lin, Zhi Ming Li, Wei Fan, Xiaojie Fang, Huangming Hong, Qing Liu, Ying Tian, Hanyu Wang, Tongyu Lin, Fangfang Li, Xiaoping Lin, Ying Huang, He Huang, Zhao Wang, Xueying Li, Qingqing Cai, Quanguang Ren, Lie Zheng
Publikováno v:
Journal of Clinical Oncology. 37:7537-7537
7537 Background: Radiotherapy is extremely important in extranodal natural killer/T-cell lymphoma (ENKTL). [18F]-Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) is a routine pretreatment imaging technique used in ENKTL, w
Autor:
Christopher Sweeney, Anis A. Hamid, Cecile Vicier, Ying Huang, Leigh Ellis, Katherine L. Morel, Lillian Werner
Publikováno v:
Journal of Clinical Oncology. 37:e16601-e16601
e16601 Background: We previously showed that loss of PTEN by quantitative multiplex immunofluorescence (qIF) is associated with relapse after prostatectomy. Low expression of TTP, which modulates the NF-kB pathway and inflammation, is prognostic for
Autor:
Christopher Sweeney, Massimo Loda, Cecile Vicier, Anis A. Hamid, Lillian Werner, Ying Huang, Carolyn Evan
Publikováno v:
Journal of Clinical Oncology. 37:86-86
86 Background: Given limited information about the prostate cancer (PC) immune infiltrate in men with localized disease, we profiled 6 markers and correlated them with risk of metastases after RP, using a single-institution cohort. Methods: Using a t
Autor:
Massimo Loda, Christopher Sweeney, Michaela Bowden, Ying Huang, Mark Pomerantz, Kathryn P. Gray, Anis A. Hamid
Publikováno v:
Journal of Clinical Oncology. 36:15-15
15 Background: Loss of PTEN expression correlates with poorer clinical outcomes after definitive therapy for non-metastatic (M0) PrCa. While most studies have used biochemical-based end points, there is limited data regarding PTEN loss by IHC and ris
Autor:
Ying Huang, Sheheryar Kabraji, Michaela Bowden, Dennis C. Sgroi, Aditya Bardia, Clyde Bango, Massimo Loda, Xavier Solé, Sridhar Ramaswamy
Publikováno v:
Journal of Clinical Oncology. 35:11579-11579
11579 Background: The mechanisms that allow triple negative breast cancer (TNBC) tumors to survive neoadjuvant chemotherapy (NACT) are incompletely understood. Evidence suggests that proliferative heterogeneity may contribute to primary chemotherapy
Publikováno v:
Journal of Clinical Oncology. 13:1409-1416
PURPOSE To determine the relationship between acute gastrointestinal (GI) toxicity during the combined modality segment and the volume of small bowel in the pelvic radiation field in patients who receive either preoperative or postoperative therapy f
Autor:
Li Tian, Tongyu Lin, Taixiang Lu, Shaoxiong Wu, Zhijun Duan, Fei Han, Chun-yan Chen, Lie Zheng, Junfang Liao, Ying Huang, Mei Lan
Publikováno v:
Journal of Clinical Oncology. 34:6039-6039
6039Background: Effective prognostic factors for stage IVA/B nasopharyngeal carcinoma (NPC) patients are limited. Fibrinolysis activation and cervical nodal necrosis (CNN) have been observed with a...
Autor:
Ying Huang, Xiaohong Fu, Linzhu Zhai, Tingzhi Liu, Yabing Cao, Taixiang Lu, Zhao Wang, He Huang, Xueying Li, Ying Tian, Mengping Zhang, Chaoyong Liang, Xiaojie Fang, Dr.Prem Raj Shrestha, Chengcheng Guo, Shanshan Li, Tongyu Lin, Huangming Hong, Jia Tian Lin, Xiaoting Lin
Publikováno v:
Journal of Clinical Oncology. 32:e17007-e17007
e17007 Background: Distant mNPC, commonly treated with platinum-based chemotherapy, is conventionally considered as an incurable disease. We explored the efficacy and survival of cetuximab plus pla...